[EN] GCN2 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE GCN2 ET LEURS UTILISATIONS
申请人:MERCK PATENT GMBH
公开号:WO2019148132A1
公开(公告)日:2019-08-01
The present invention provides compounds, compositions thereof, and methods of using the same.
本发明提供了化合物、其组合物以及使用它们的方法。
Indole derivatives
申请人:Ratcliffe David Paul
公开号:US20070082931A1
公开(公告)日:2007-04-12
Disclosed herein are indole derivatives of the formula (I)
wherein each of the substitutents is given the definition as set forth in the specification and claims. Also disclosed are pharmaceutical compositions containing the indole derivatives and use of the derivatives for the treatment of pain.
[EN] THIENO [2, 3 -D] PYRIMIDINE DERIVATIVES AND THEIR USE TO TREAT ARRHYTHMIA<br/>[FR] DÉRIVÉS DE THIÉNO[2,3-D]PYRIMIDINE ET LEUR UTILISATION POUR TRAITER L'ARYTHMIE
申请人:XENTION LTD
公开号:WO2012131379A1
公开(公告)日:2012-10-04
The present invention relates to thienopyrimidine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia are also described.
THIENO [2, 3-D] PYRIMIDINE DERIVATIVES AND THEIR USE TO TREAT ARRHYTHMIA
申请人:Ford John
公开号:US20140206703A1
公开(公告)日:2014-07-24
The present invention relates to thienopyrimidine compounds which are potassium channel inhibitors. Pharmaceutical compositions comprising the compounds and their use in the treatment of arrhythmia are also described.
SYNERGISTIC COMBINATION FOR THE TREATMENT OF PAIN (CANNABINOID RECEPTOR AGONIST AND OPIOID RECEPTOR AGONIST)
申请人:Adam-Worrall Julia
公开号:US20090029984A1
公开(公告)日:2009-01-29
The invention relates to a pharmaceutical dosage form comprising an analgesic combination for simultaneous or sequential use which comprises a peripherally restricted cannabinoid CB1 receptor agonist having a brain C
max
to plasma C
max
ratio of less than 0.1 and an opioid receptor agonist, as well as to a method for treating pain using said pharmaceutical dosage form.